Dr. Milica Vukmirovic has over 10 years of experience in early-stage technology and venture development, focused on building go-to-market strategies, business development, IP, licensing and fundraising, across diverse roles in university initiatives, accelerators and investment funds in US, Europe and Canada.
She specializes in complex integration of market, customer, competitors, and organizational strategies for drug and medical device development from pre-clinical to early clinical stages. Key to successful venture development is identifying unique value proposition of innovative technology to address unmet need in time and place favorable for technology development and fundraising.
Dr. Vukmirovic spearheaded the National adMare BioInnovation Therapeutics (Tx) Accelerator across British Columbia, Quebec, and Ontario, in collaboration with MaRS, fostering a federal stronghold in bioinnovation.
As Director of External Programs and Partnerships with Precision Medicine initiative (PRiME) at the University of Toronto, Canada, she worked on translational projects with multidisciplinary teams of researchers to support commercialization and fundraising opportunities for early-stage technology development.
Previously, Dr. Vukmirovic was a Blavantik Fellow and worked closely with the Blavatnik Fund for Innovation at Yale. Following Yale, she served as an Innovation & Commercialization Consultant at The Research Institute of St. Joe’s Hamilton & Lead Health Innovation Coach at the Clinic@Joe’s & Michael G. DeGroote Health Innovation, Commercialization & Entrepreneurship initiative at McMaster University.
As a co-Chair for Respiratory, Cell and Molecular Biology Assembly at American Thoracic Society (ATS), Innovation and Entrepreneurial working group, Dr. Vukmirovic supports entrepreneurship in academic pulmonary medicine and research.
Dr. Vukmirovic holds PhD in Cancer Cell Biology from University of Lausanne, Switzerland and post-doctoral trainings from Yale and Florida State University. Over the course of her academic career, she published 18 peer-reviewed articles (>5 in top respiratory journals).
